Sleep Screening Devices Market : Global Industry Analysis and Opportunity Assessment, 2035

Sleep Screening Devices Market Trends and Forecast 2025 to 2035

  • Industry Size (2025): USD 10579.3 Mn
  • Forecast (2035): USD 20617.5 Mn
  • CAGR (2025 to 2035): 6.9%
Methodology

Sleep Screening Devices Market Size and Share Forecast Outlook 2025 to 2035

The global sleep screening devices market is estimated to be valued at USD 10,579.3 million in 2025 and is projected to reach USD 20,617.5 million by 2035, registering a CAGR of 6.9% over the forecast period.

Quick Stats for Sleep Screening Devices Market

  • Industry Value (2025): USD 10,579.3 million
  • Forecast Value (2035): USD 20,617.5 million
  • Forecast CAGR: 6.9%
  • Leading Segment in 2025: Wearable Devices (42.6% share)
  • Key Growth Region: North America, Asia Pacific
  • Top Key Players: ResMed Inc., Itamar Medical Ltd., Philips Respironics, Natus Medical Incorporated, Cleveland Medical Devices Inc.
Metric Value
Industry Size (2025E) USD 10,579.3 million
Industry Value (2035F) USD 20,617.5 million
CAGR (2025 to 2035) 6.9%

The sleep screening devices market has experienced strong momentum as healthcare providers, employers, and consumers increasingly recognize the impact of sleep disorders on overall health and productivity.

Rising awareness of sleep apnea, insomnia, and circadian rhythm disruptions has contributed to higher demand for accessible screening tools capable of early identification and continuous monitoring. Advances in wearable technologies and connected devices have enhanced user engagement, enabling real-time data collection and integration with mobile applications.

Analyzing Sleep Screening Devices Market by Top Investment Segments

Wearable Devices Lead the Market with Demand for Continuous, User-Friendly Sleep Tracking Solutions

Wearable Devices to hold a revenue share of 42.6% in the global sleep screening devices market. Adoption has been driven by the availability of wristbands, rings, and headbands equipped with advanced sensors capable of monitoring multiple sleep parameters in real time. Integration with smartphone applications has enabled users to access personalized insights and trend analyses, increasing engagement and adherence.

Manufacturers have prioritized ergonomics, battery life, and data accuracy to differentiate products and build trust among users. Marketing strategies emphasizing self-empowerment and wellness optimization have contributed to sustained demand. These factors have established wearables as the leading product segment, with continued growth expected as technology and consumer awareness evolve.

Application Segment Sub-Header Sleep Apnea Screening Drives the Market with Rising Recognition of Undiagnosed and Untreated Cases

Sleep Apnea Leads the revenue share by 37.7% which has been attributed to sleep apnea screening, underscoring its central role in the diagnosis of sleep-related breathing disorders. Utilization has been driven by growing awareness of the health risks associated with untreated obstructive sleep apnea, including cardiovascular disease and metabolic disorders.

Clinicians and employers have prioritized early screening programs to improve outcomes and reduce long-term healthcare costs. Advances in wearable sensors and portable devices have enabled accurate home-based detection of apneic episodes, increasing accessibility for patients hesitant to undergo in-lab studies.

Retail Stores Anchor the Market with Accessible Distribution and Growing Consumer Preference for Self-Care Solutions

Retail stores have accounted for 40.1% of revenue, supported by expanding consumer interest in self-directed sleep monitoring and wellness optimization. Adoption of sleep screening devices through retail channels has been driven by the convenience of in-store availability and the ability for consumers to compare multiple products before purchase.

Major retailers and pharmacy chains have prioritized partnerships with leading manufacturers to offer curated selections of FDA-cleared wearables and home sleep monitors. Investments in in-store displays, staff training, and consumer education materials have strengthened engagement and improved purchasing confidence. Integration of devices with digital health platforms and loyalty programs has further enhanced appeal among health-conscious shoppers.

Challenges and Opportunities

Challenge

Accuracy Concerns and Lack of Standardization

The scattered accuracy exhibited between consumer and clinical sleep screening devices, as well as the absence of any unified regulatory standards, brings forth hurdles for the sleep screening devices market.

Home-based sleep trackers and wearables may be conveniently used. However, most do not provide diagnoses as reliable as those offered by the in-laboratory PSG for conditions such as obstructive sleep apnea (OSA). Secondly, false-positive or underdiagnosis may cause a delay in intervention.

This is further exacerbated by variation in reimbursement for home sleep tests that will be obtained depending on the territory and payer. Different types of devices-from wristbands to under-mattress sensors-serve to confuse clinician trust and complicate the integration into the electronic health records and treatment workflow.

Opportunity

Demand for At-Home Sleep Monitoring and Rise of Digital Health

The market for sleep devices is expanding at an increasing pace because of the awareness of sleeping disorders and the need for diagnostics that can easily be done at home. Portable sleep monitors and AI-enabled wearables are being used for non-invasive tracking of sleep patterns and oxygen levels and respiratory effort, which helps in the early diagnosis of problems like insomnia, OSA, and circadian rhythm disorders.

The constant move towards personalized wellness, virtual care, and Remote Patient Monitoring strengthens integration of its device into digital health architectures. As chronic sleep disorders become closely associated with various metabolic and mental health disorders, accurate scalable screening solutions become increasingly important in both preventive care and long-term disease management.

Country-Wise Outlook

United States

The sleep screening devices market shows a steady growth trend in the US due to a very high prevalence of obstructive sleep apnea (OSA), increased awareness towards sleep disorders, and insurance coverage for home-based diagnostics.

Evidence of this change comes in the growing prescription of portable sleep monitors and wearables by healthcare providers. Meanwhile, consumers are demanding more FDA-endorsed app-connected sleep diagnostic tools that will drive early detection and CPAP adherence monitoring.

Country CAGR (2025 to 2035)
USA 6.7%

United Kingdom

This market within the UK is supported by NHS initiatives to facilitate sleep disorder diagnosis and reduce wait time for in-lab polysomnography. Portable home sleep test kits are becoming increasingly popular, especially among patients with suspected OSA and shift work-associated sleep problems.

Private clinics are also starting to utilize wearable and contactless sleep monitors for integrated wellness programs and corporate health services.

Country CAGR (2025 to 2035)
UK 6.6%

European Union

Within the greater European Union member states, sleep screening devices have a booming and thriving market. They have been discovered and invented into a large full market in Germany, France, and the Netherlands. More and more hospitals and sleep labs are integrating these wireless diagnostic tools into their services; home health has also widened its coverage with more patients getting access to portable screening units.

The alignment of EU regulations for digital medical devices includes such encouragement for the development of CE-marked wearable and bedside units, which are already being supported in their wide-scale deployment into primary care.

Region CAGR (2025 to 2035)
European Union 6.9%

Japan

The sleep monitoring market in Japan is steadily expanding due to public awareness of sleep hygiene, increased use of home sleep testing, and aging raising the prevalence of sleep-related disorders. The ultra-compact, non-invasive sleep monitoring systems are currently being developed by Japanese firms for clinical and consumer applications.

In fact, hospitals and primary care providers are partnering with device manufacturers to provide an at-home diagnosis for suspected OSA and REM behavior disorders.

Country CAGR (2025 to 2035)
Japan 6.5%

South Korea

South Korea is witnessing strong growth in the sleep screening devices market, powered by its digital health infrastructure and rising cases of sleep disorders linked to urban lifestyles and mental health stressors. South Korean startups and electronics firms are integrating AI and cloud connectivity into sleep tracking headbands, rings, and mattress-based sensors.

Medical-grade home testing kits are being used in sleep clinics, telehealth programs, and health insurance wellness initiatives.

Country CAGR (2025 to 2035)
South Korea 7.3%

Competition Outlook

The competitive landscape has been shaped by companies investing in advanced sensors, digital platforms, and global distribution partnerships to strengthen market position. Leading manufacturers have introduced next-generation wearables with multi-parameter monitoring, cloud integration, and artificial intelligence-based analytics.

Strategic alliances with manufacturers and insurers have been pursued to drive adoption through workplace wellness initiatives. Direct-to-consumer marketing campaigns and influencer collaborations have been launched to increase brand awareness and credibility. These activities are expected to sustain innovation and intensify competition as sleep health becomes an increasingly important focus of preventive care.

Key Development

In 2024, Apple today unveiled breakthrough sleep and hearing health features coming to Apple Watch and AirPods Pro 2 that further deliver on Apple’s commitment to health with experiences that enrich users’ lives.

In 2025, Resmed today announced its home sleep apnea test, NightOwl™, is now available across the United States. NightOwl is an FDA-cleared home sleep apnea test (HSAT) designed to offer healthcare providers a simplified, accurate, and efficient way to diagnose obstructive sleep apnea (OSA) from the comfort of an individual’s home.

Companies

  • Koninklijke Philips N.V
  • Google Inc.
  • Garmin Ltd.
  • Fossil Group, Inc.
  • Huawei Technologies Co., Ltd.
  • ResMed Inc.
  • NovaSom
  • Itamar Medical Ltd.
  • Ez Sleep
  • ApneaMed
  • SleepWorks, LLC
  • VirtuOx, Inc.
  • Apple Inc.
  • Sleep Shepherd LLC
  • Samsung Electronics
  • Natus Medical
  • Advanced Brain Monitoring
  • Cleveland Medical Devices Inc.

Key Segments

By Product Type:

  • Sleep Monitors
  • Wearables
  • Headband Devices
  • Wrist Devices & Hand Bands Devices
  • Ring Devices
  • Sleep Mask Tracker Devices
  • Non-wearables
  • Bedside Non-Wearable Devices
  • Under Sheet Non-Wearable Devices
  • Under Mattress Non-Wearable Devices
  • Smart Sleep Equipment
  • Others

By Application:

  • Circadian Rhythm Disorders
  • Sleep Deprivation
  • Narcolepsy
  • Sleep Apnea
  • Insomnia

By Distribution Channel:

  • Hypermarkets and Supermarkets
  • Retail Stores
  • Pharmacy
  • Online

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

Frequently Asked Questions

What was the overall size of the sleep screening devices market in 2025?

The overall market size for the sleep screening devices market was USD 10,579.3 million in 2025.

How big is the sleep screening devices market expected to be in 2035?

The sleep screening devices market is expected to reach USD 20,617.5 million in 2035.

What will drive the demand for the sleep screening devices market during the forecast period?

The increasing prevalence of sleep disorders, rising awareness of sleep health, and growing use of wearable devices for sleep apnea detection fuel the sleep screening devices market during the forecast period.

List the top 5 countries contributing to the sleep screening devices market?

The top 5 countries driving the development of the sleep screening devices market are the USA, UK, European Union, Japan, and South Korea.

Which segment in type is expected to lead in the sleep screening devices market?

Wearable devices and sleep apnea detection lead market growth to command a significant share over the assessment period.

Table of Content

  1. Executive Summary
  2. Industry Introduction, including Taxonomy and Market Definition
  3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
  4. Global Market Demand Analysis 2020 to 2024 and Forecast 2025 to 2035, including Historical Analysis and Future Projections
  5. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035
    • Product Type
    • Application
    • Distribution Channel
  6. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Product Type
    • Sleep Monitors
    • Wearables
    • Headband Devices
    • Wrist Devices & Hand Bands Devices
    • Ring Devices
    • Sleep Mask Tracker Devices
    • Non-wearables
    • Bedside Non-Wearable Devices
    • Under Sheet Non-Wearable Devices
    • Under Mattress Non-Wearable Devices
    • Smart Sleep Equipment
    • Others
  7. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Application
    • Circadian Rhythm Disorders
    • Sleep Deprivation
    • Narcolepsy
    • Sleep Apnea
    • Insomnia
  8. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Distribution Channel
    • Hypermarkets and Supermarkets
    • Retail Stores
    • Pharmacy
    • Online
  9. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
    • North America
    • Latin America
    • Western Europe
    • Eastern Europe
    • East Asia
    • South Asia Pacific
    • Middle East and Africa
  10. North America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  11. Latin America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  12. Western Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  13. Eastern Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  14. East Asia Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  15. South Asia Pacific Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  16. Middle East and Africa Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  17. Sales Forecast 2025 to 2035 by Product Type, Application, and Distribution Channel for 30 Countries
  18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
  19. Company Profile
    • ResMed Inc.
    • Itamar Medical Ltd. (a ZOLL company)
    • Philips Respironics (Philips N.V.)
    • Natus Medical Incorporated
    • Cleveland Medical Devices Inc. (CleveMed)
    • Withings
    • Oura Health Oy
    • Fitbit (Google)
    • Neurovalens Ltd.
    • VirtuOx Inc.